We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$15.3B
1-Year Est. Return
50.95%
This Fund
S&P 500
This Quarter
Est. Return
+3.56%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$12B
AUM Growth
+$2B
(+20%)
Cap. Flow
+$2.04B
Cap. Flow
% of AUM
17.04%
Top 10 Holdings %
Top 10 Hldgs %
49.1%
Holding
107
New
26
Increased
43
Reduced
12
Closed
21
Top Buys
| 1 |
COL
Rockwell Collins
COL
|
+$391M |
| 2 |
MON
Monsanto Co
MON
|
+$386M |
| 3 |
Keurig Dr Pepper
KDP
|
+$362M |
| 4 |
LOGM
LogMein, Inc.
LOGM
|
+$212M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$182M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
+$306M |
| 2 |
AABA
Altaba Inc
AABA
|
+$248M |
| 3 |
AB InBev
BUD
|
+$164M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$163M |
| 5 |
Huntsman Corp
HUN
|
+$80.7M |
Sector Composition
| 1 | Technology | 25.94% |
| 2 | Healthcare | 17.57% |
| 3 | Communication Services | 16.49% |
| 4 | Financials | 13.71% |
| 5 | Industrials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Liberty Global Class A
LBTYA
$3.69B
| $148M | 1.23% |
4,713,926
+1,443,746
| +44% | +$49.9M |
|
27
Fidelity National Information Services
FIS
$21.7B
| $147M | 1.23% |
1,527,538
-503,838
| -25% | -$49.4M |
|
|
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
| $147M | 1.23% |
4,086,300
+150,000
| +4% | +$5.42M |
|
29
Gilead Sciences
GILD
$163B
| $137M | 1.15% |
+1,820,000
| New | +$145M |
|
|
ABLX
30
DELISTED
Ablynx NV
ABLX
| $134M | 1.12% |
2,450,000
+100,000
| +4% | +$4.96M |
|
31
AstraZeneca
AZN
$263B
| $125M | 1.04% |
1,782,500
-100,000
| -5% | -$6.93M |
|
|
PPLI
32
People Inc
PPLI
$3.41B
| $112M | 0.93% |
+4,000,716
| New | +$105M |
|
|
TWX
33
DELISTED
Time Warner Inc
TWX
| $96.5M | 0.81% |
1,020,000
-3,245,000
| -76% | -$306M |
|
34
Biogen
BIIB
$30.9B
| $93.1M | 0.78% |
340,000
-200,000
| -37% | -$62.1M |
|
35
Ascendis Pharma A/S
ASND
$17.4B
| $84.2M | 0.7% |
+1,286,800
| New | +$72.3M |
|
|
KYNB
36
Kyntra Bio
KYNB
$29.7M
| $79.3M | 0.66% |
68,700
+2,400
| +4% | +$3.16M |
|
|
XL
37
DELISTED
XL Group Ltd.
XL
| $74.9M | 0.63% |
+1,355,000
| New | +$59.5M |
|
38
Enanta Pharmaceuticals
ENTA
$397M
| $74M | 0.62% |
915,000
-10,000
| -1% | -$770K |
|
|
ESRX
39
DELISTED
Express Scripts Holding Company
ESRX
| $71.8M | 0.6% |
+1,040,000
| New | +$79.3M |
|
|
SAGE
40
DELISTED
Sage Therapeutics
SAGE
| $71.7M | 0.6% |
445,000
+45,000
| +11% | +$7.64M |
|
41
Iovance Biotherapeutics
IOVA
$1.8B
| $70.1M | 0.59% |
4,150,000
+2,283,100
| +122% | +$34.6M |
|
|
HRG
42
DELISTED
HRG Group, Inc.
HRG
| $66.6M | 0.56% |
4,040,000
+2,898,000
| +254% | +$48.4M |
|
|
ZGNX
43
DELISTED
Zogenix, Inc.
ZGNX
| $63.1M | 0.53% |
1,576,000
+726,000
| +85% | +$28.8M |
|
|
XLRN
44
DELISTED
Acceleron Pharma
XLRN
| $54.8M | 0.46% |
1,401,000
+313,000
| +29% | +$13.3M |
|
45
Qualcomm
QCOM
$194B
| $53.2M | 0.44% |
960,000
+170,217
| +22% | +$10.8M |
|
|
FOLD
46
DELISTED
Amicus Therapeutics
FOLD
| $52.4M | 0.44% |
3,481,000
+700,000
| +25% | +$10.7M |
|
47
Bunge Global
BG
$22.8B
| $51M | 0.43% |
690,000
+585,000
| +557% | +$44.2M |
|
|
MYOK
48
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $50.7M | 0.42% |
1,039,278
+175,546
| +20% | +$9.13M |
|
|
ARRY
49
DELISTED
Array Biopharma Inc
ARRY
| $50.5M | 0.42% |
+3,095,000
| New | +$49.6M |
|
50
XPO
XPO
$24.6B
| $48.4M | 0.4% |
1,373,412
+1,113,187
| +428% | +$37.1M |
|
Similar funds
UM
RFC
HWM
NMO
EH
MSV